$20.79 Million in Sales Expected for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) This Quarter

Retrieved on: 2021-02-03 08:37:30

Tags for this article:

Click the tags to see associated articles and topics

$20.79 Million in Sales Expected for Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) This Quarter. View article details on hiswai:

Excerpt

Acadian Asset Management LLC now owns 224,542 shares of the specialty pharmaceutical company's stock valued at $925,000 after buying an ...

Article found on: www.marketbeat.com